Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
10 Results for "
Lilra5
" in MedChemExpress (MCE) Product Catalog:
Products (10)
10 Results for "Lilra5" in MCE Product Catalog:
Cat. No.: HY-RS07649
Target:
Domaines de recherche:
LILRA5 Human Pre-designed siRNA Set A contains three designed siRNAs for LILRA5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS19514
Target:
Domaines de recherche:
Lilra5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Lilra5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS26008
Target:
Domaines de recherche:
Lilra5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Lilra5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P75909
Pureté: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Lilra5; Leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Human
Source:
HEK293
Cat. No.: HY-P75910
Pureté: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Lilra5; Leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Human
Source:
HEK293
Cat. No.: HY-P77062
Pureté: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Lilra5; Leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Rat
Source:
HEK293
Cat. No.: HY-P78481
Pureté: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: Lilra5; Leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Human
Source:
HEK293
Cat. No.: HY-P77063
Pureté: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Lilra5; Leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Rat
Source:
HEK293
Cat. No.: HY-P72521
Pureté: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Lilra5; Leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Human
Source:
HEK293
Cat. No.: HY-P72394
Pureté: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Lilra5; Leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Human
Source:
HEK293
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
